CHEMOTHERAPEUTIC-AGENTS AND MODULATION OF NATURAL-KILLER CELL-ACTIVITY INVITRO

被引:24
作者
CHARAMELLA, LJ [1 ]
MEYER, C [1 ]
THOMPSON, GE [1 ]
DIMITROV, NV [1 ]
机构
[1] MICHIGAN STATE UNIV,DEPT MED,E LANSING,MI 48824
来源
JOURNAL OF IMMUNOPHARMACOLOGY | 1985年 / 7卷 / 01期
关键词
D O I
10.3109/08923978509026469
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:53 / 65
页数:13
相关论文
共 28 条
[1]   INTERFERON ENHANCED HUMAN NATURAL KILLER AND ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXIC ACTIVITY [J].
ATTALLAH, AM ;
FOLKS, T .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1979, 60 (04) :377-382
[2]   ENHANCEMENT OF HUMAN NATURAL-KILLER CELLS BY INTERFERON REQUIRES RNA AND PROTEIN-SYNTHESIS [J].
BISHOP, GA ;
SCHWARTZ, SA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1982, 25 (03) :374-385
[3]  
BLOMGREN H, 1976, ACTA MED SCAND, V199, P527
[4]  
Cantell K, 1981, Methods Enzymol, V78, P29
[5]   HUMAN-LEUKOCYTE INTERFERON THERAPY FOR ADVANCED OVARIAN-CARCINOMA [J].
EINHORN, N ;
CANTELL, K ;
EINHORN, S ;
STRANDER, H .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (02) :167-172
[6]  
EINHORN S, 1978, ACTA MED SCAND, V204, P477
[7]   INTERFERON AND SPONTANEOUS CYTO-TOXICITY IN MAN .5. ENHANCEMENT OF SPONTANEOUS CYTO-TOXICITY IN PATIENTS RECEIVING HUMAN-LEUKOCYTE INTERFERON [J].
EINHORN, S ;
BLOMGREN, H ;
STRANDER, H .
INTERNATIONAL JOURNAL OF CANCER, 1980, 26 (04) :419-428
[8]  
Einhorn S, 1978, Adv Exp Med Biol, V110, P159
[9]   INTERFERON AND NATURAL-KILLER ACTIVITY IN MULTIPLE-MYELOMA - LACK OF CORRELATION BETWEEN INTERFERON-INDUCED ENHANCEMENT OF NATURAL-KILLER ACTIVITY AND CLINICAL-RESPONSE TO HUMAN INTERFERON-ALPHA [J].
EINHORN, S ;
AHRE, A ;
BLOMGREN, H ;
JOHANSSON, B ;
MELLSTEDT, H ;
STRANDER, H .
INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (02) :167-172
[10]   INTERFERON AND SPONTANEOUS CYTOTOXICITY IN MAN .1. ENHANCEMENT OF SPONTANEOUS CYTOTOXICITY OF PERIPHERAL LYMPHOCYTES BY HUMAN LEUKOCYTE INTERFERON [J].
EINHORN, S ;
BLOMGREN, H ;
STRANDER, H .
INTERNATIONAL JOURNAL OF CANCER, 1978, 22 (04) :405-412